LifeMD, Inc.

NASDAQ:LFMD

Medical - Pharmaceuticals

Healthcare
$1.70 -3.27%

-$0.16 today

Market cap
$82.17M
Beta
1.99
P/E (TTM)
-13.8
EPS (TTM)
-$0.34
52W Low $2.56High $15.84

Volume 0.80M

Average 1.04M

LFMD Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

LifeMD, Inc.NASDAQ: LFMD

Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026

Capital expenditures dips below year-ago levels

Q1 FY2026 capital expenditures of $105.17K (cash outflow) fell 96.3% year over year, behind the +175.1% change in trailing-twelve-month capital expenditures. Sequentially, it fell 32.3% from the prior quarter. Over 3 fiscal years it compounded at -9.6% a year.

Context

  • Capital expenditures amounted to 4.9% of revenue in FY2025, down 0.5 pp from a year earlier.
  • Capital expenditures grew in size in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -96.3% toward the trailing-twelve-month pace of +175.1%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$105.17K-32.3% QoQ
Last fiscal yearDec 2025
-$9.52M-17.5% YoY
LTMMar 2026
$9.17M+175.1% YoY
Capital Expenditures past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-96.3%——
1 year-17.5%——
3-year CAGR-9.6%——
5-year CAGR——
10-year CAGR——

Capital Expenditures history

USD · from the cash flow

Latest · FY2025
(9.52M) USD
Year-over-year change
+17.5%

Capital Expenditures vs competitors

How LFMD compares with its peers on the latest reported figures

  • Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +175.1% is the highest of 10, against a peer median of -4.6%.
  • Capital expenditures amounts to 4.2% of revenue for LFMD, versus a peer median of 1.5%.
LFMD Competitors
Capital Expenditures for LFMD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HITIHigh Tide Inc.LTM Apr 2026CA$10.14M CAD-5.9%+5.5%1.5%
LFMDLifeMD, Inc.LTM Mar 2026$9.17M USD+175.1%-9.6%4.2%
TBRGTruBridge, Inc.LTM Mar 2026$4.68M USD-74.6%-59.1%1.4%
CERSCerus CorporationLTM Mar 2026$3.85M USD+108.1%+12.4%1.7%
SMTISanara MedTech Inc.LTM Mar 2026$2.95M USD+56.2%+83.6%2.7%
TKNOAlpha Teknova, Inc.LTM Mar 2026$1.16M USD-4.6%-65.6%2.8%
MASS908 Devices Inc.LTM Mar 2026$836K USD-688.7%-22.4%1.4%
SENSSenseonics Holdings, Inc.LTM Mar 2026$793K USD-66.4%+52.9%1.9%
CVRXCVRx, Inc.LTM Mar 2026$588K USD+5.4%-5.4%1.0%
SGHTSight Sciences, Inc.LTM Mar 2026$284K USD+6.0%-38.6%0.4%
Peer median (excluding LFMD) —-4.6%-5.4%1.5%

Competitors are the stored peer set for LFMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(61.32M)(45.02M)(20.6M)(18.73M)15.62M
Depreciation & Amortization868.76K3.77M6.6M9.49M328.37K
Deferred Income Tax0354K000
Stock-Based Compensation12.07M13.73M12.49M12.23M10.5M
Change in Working Capital9.13M(1.55M)4.91M12.65M(7.85M)
Accounts Receivables17.7K(2.19M)(2.44M)(2.94M)1.15M
Inventory(409.82K)(2.18M)764.33K675.67K303.24K
Accounts Payables(893.96K)1.25M978.06K4.92M3.24M
Other Working Capital10.42M1.58M5.61M9.99M(12.55M)
Other Non-Cash Items6.17M5.78M5.42M1.87M(10.31M)
Operating Cash Flow(33.09M)(22.94M)8.82M17.51M8.28M
Capital Expenditures(3.4M)(12.89M)(8.73M)(11.54M)(9.52M)
Acquisitions (Net)0(1.01M)000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(3.15M)(12.53M)(8.53M)(10.05M)8.78M
Investing Cash Flow(3.4M)(13.91M)(8.73M)(11.54M)6.91M
Debt Repayment(530.82K)2.74M16.67M(327.6K)(18.72M)
Common Stock Issued13.99M016.2M09.19M
Common Stock Repurchased00000
Dividends Paid(871.48K)(3.11M)(3.11M)(3.11M)(3.11M)
Other Financing Activities707.36K(159.2K)(667.63K)(684.83K)(773.66K)
Financing Cash Flow68.64M(528.2K)29.1M(4.12M)(13.41M)
Effect of Forex Changes00000
Net Change in Cash32.15M(37.37M)29.19M1.86M1.78M
Free Cash Flow(36.49M)(35.83M)86.95K5.98M(1.24M)

LifeMD, Inc.

NASDAQ:LFMD

Intrinsic Alpha fair value

Locked

Current Price

$1.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.